0,851  0,003  Caspase 3 stimulant
0,762  0,004  5 Hydroxytryptamine release stimulant
0,767  0,012  Antineoplastic (breast cancer)
0,754  0,004  Antineoplastic (brain cancer)
0,748  0,005  Antineoplastic (glioma)
0,753  0,013  Antineoplastic (lung cancer)
0,737  0,004  Antimitotic
0,753  0,022  Antiinflammatory
0,748  0,023  Apoptosis agonist
0,719  0,013  Antineoplastic (colorectal cancer)
0,717  0,012  Antineoplastic (colon cancer)
0,706  0,006  NOS2 expression inhibitor
0,699  0,006  Cardiovascular analeptic
0,703  0,011  Alzheimer's disease treatment
0,693  0,005  Cardioprotectant
0,690  0,025  Caspase 9 stimulant
0,677  0,015  Antileukemic
0,642  0,003  ICAM1 expression inhibitor
0,644  0,009  Antioxidant
0,613  0,009  Nitric oxide antagonist
0,606  0,004  Diabetic nephropathy treatment
0,610  0,017  Prostate cancer treatment
0,576  0,004  VCAM1 expression inhibitor
0,589  0,020  Antiparkinsonian
0,593  0,032  Transcription factor NF kappa B inhibitor
0,552  0,005  Cyclic AMP phosphodiesterase inhibitor
0,564  0,020  Antihypercholesterolemic
0,534  0,009  Vasodilator
0,538  0,022  Antineoplastic (ovarian cancer)
0,514  0,004  Pneumotoxic
0,525  0,018  CYP2C19 inhibitor
0,518  0,012  Antineoplastic (glioblastoma multiforme)
0,512  0,018  Chemopreventive
0,506  0,016  Antiprotozoal (Leishmania)
0,496  0,012  Antidiabetic symptomatic
0,500  0,016  Free radical scavenger
0,481  0,004  Estrogen agonist
0,497  0,023  Antineoplastic (cervical cancer)
0,515  0,043  TNF expression inhibitor
0,503  0,032  Aldehyde oxidase inhibitor
0,469  0,003  Nitric-oxide synthase stimulant
0,460  0,004  Histone deacetylase stimulant
0,460  0,004  Histone deacetylase SIRT1 stimulant
0,488  0,037  Antipruritic, allergic
0,500  0,050  Antidiabetic
0,500  0,050  Cyclophilin D inhibitor
0,492  0,042  15-Lipoxygenase inhibitor
0,467  0,018  Antipyretic
0,459  0,020  Antiamyloidogenic
0,461  0,026  Antineoplastic (pancreatic cancer)
0,460  0,026  Apoptosis antagonist
0,438  0,007  GST M1-1 substrate
0,459  0,029  Hepatic disorders treatment
0,433  0,009  5 Hydroxytryptamine uptake stimulant
0,460  0,037  Mood disorders treatment
0,419  0,003  Carcinogenic, group 2A
0,452  0,040  Vasodilator, peripheral
0,430  0,020  UGT1A6 substrate
0,442  0,037  Antidepressant
0,414  0,011  Tubulin antagonist
0,433  0,032  Cytotoxic
0,434  0,034  Antineoplastic (melanoma)
0,406  0,010  Genotoxic
0,433  0,041  Antiallergic
0,416  0,027  UGT2B4 substrate
0,414  0,030  Antineoplastic (non-small cell lung cancer)
0,387  0,014  Hepatoprotectant
0,380  0,008  Antidiarrheal
0,397  0,025  Calcium channel activator
0,425  0,063  Histamine release inhibitor
0,394  0,036  UGT1A9 substrate
0,394  0,037  Vasodilator, coronary
0,390  0,035  Cytostatic
0,355  0,006  Carcinogenic, group 1
0,355  0,011  UGT2B15 substrate
0,372  0,030  Antineoplastic (renal cancer)
0,361  0,019  Antimutagenic
0,354  0,013  Cholinergic
0,345  0,004  Estrogen receptor beta agonist
0,356  0,015  Antineoplastic (squamous cell carcinoma)
0,399  0,059  Ulceration
0,372  0,034  Proliferative diseases treatment
0,371  0,038  Sensitization
0,346  0,016  Melanin inhibitor
0,347  0,025  Antineoplastic (sarcoma)
0,383  0,066  CYP2C9 inhibitor
0,361  0,046  CYP3A4 inhibitor
0,323  0,011  Acetylcholinesterase inhibitor
0,322  0,012  Bipolar disorder treatment
0,314  0,005  Beta amyloid protein antagonist
0,382  0,074  GST A substrate
0,318  0,011  Glutathione S-transferase substrate
0,322  0,016  Amylase inhibitor
0,343  0,038  Antineoplastic (small cell lung cancer)
0,402  0,104  Antineoplastic (solid tumors)
0,322  0,027  UGT1A1 substrate
0,349  0,055  Antiischemic
0,309  0,017  Topoisomerase II inhibitor
0,317  0,026  P-glycoprotein inhibitor
0,344  0,053  Lipoxygenase inhibitor
0,296  0,010  Cystathionine beta-synthase inhibitor
0,323  0,037  Psychostimulant
0,299  0,018  Neurotrophic factor enhancer
0,327  0,048  DNA damaging
0,301  0,022  Antipruritic, non-allergic
0,392  0,119  Alpha-glucosidase inhibitor
0,290  0,019  NOS3 expression enhancer
0,347  0,079  CYP3A4 substrate
0,313  0,047  Antineoplastic (lymphoma)
0,274  0,008  Alpha 2c adrenoreceptor antagonist
0,324  0,060  CTGF expression inhibitor
0,290  0,029  UGT2B7 substrate
0,323  0,064  NOS3 expression inhibitor
0,281  0,024  Antineoplastic (carcinoma)
0,264  0,010  UGT2B10 substrate
0,268  0,017  Antineoplastic (bone cancer)
0,357  0,109  5 Hydroxytryptamine release inhibitor
0,256  0,009  Alpha 2a adrenoreceptor antagonist
0,283  0,036  Antihypotensive
0,291  0,045  Mutagenic
0,297  0,054  Hypoglycemic
0,254  0,011  Alpha 2 adrenoreceptor antagonist
0,312  0,071  Respiratory analeptic
0,308  0,070  Analeptic
0,314  0,079  FMO1 substrate
0,251  0,017  Topoisomerase I inhibitor
0,310  0,076  AR expression inhibitor
0,244  0,010  Microtubule formation inhibitor
0,273  0,041  Abortion inducer
0,251  0,020  LDLR expression enhancer
0,332  0,102  Antiprotozoal
0,273  0,043  Platelet aggregation inhibitor
0,258  0,030  Acaricide
0,258  0,029  UGT1A3 substrate
0,254  0,025  Skin whitener
0,237  0,009  Beta glucuronidase inhibitor
0,269  0,043  ErbB-1 antagonist
0,292  0,066  Antidiabetic (type 2)
0,256  0,033  Prostatic (benign) hyperplasia treatment
0,279  0,058  Vascular (periferal) disease treatment
0,291  0,071  Antiosteoporotic
0,292  0,072  CYP1A2 substrate
0,279  0,060  Antineoplastic (liver cancer)
0,232  0,015  Antibacterial (Helicobacter pylori)
0,288  0,072  CYP2C19 substrate
0,227  0,010  Estrogen antagonist
0,240  0,026  Succinate dehydrogenase inhibitor
0,222  0,008  Estrogen receptor beta antagonist
0,270  0,056  Antineoplastic (lymphocytic leukemia)
0,296  0,088  Antihypertensive
0,263  0,055  Antiparasitic
0,249  0,045  Antihelmintic
0,229  0,025  VEGF expression inhibitor
0,274  0,070  CYP1A2 inhibitor
0,322  0,119  Antibacterial
0,250  0,049  Sedative
0,224  0,029  UGT2B9 substrate
0,306  0,111  Immunosuppressant
0,298  0,108  CYP2C9 substrate
0,211  0,025  GST P1-1 substrate
0,208  0,023  5-Lipoxygenase inhibitor
0,209  0,025  Arachidonic acid antagonist
0,284  0,102  Cholesterol antagonist
0,254  0,072  Superoxide dismutase inhibitor
0,277  0,098  Bone diseases treatment
0,240  0,061  Antihypertriglyceridemic
0,179  0,005  Estrogen receptor alpha agonist
0,203  0,031  Antifungal enhancer
0,209  0,037  CNS active muscle relaxant
0,197  0,025  Antitussive
0,205  0,034  Phosphodiesterase inhibitor
0,192  0,022  Cyclooxygenase 3 inhibitor
0,247  0,076  Tumour necrosis factor alpha release inhibitor
0,177  0,008  Acetylcholine M3 receptor agonist
0,250  0,084  Chemoprotective
0,250  0,085  Radiosensitizer
0,252  0,088  Antineurogenic pain
0,164  0,003  Melatonin 1 agonist
0,212  0,053  UGT1A4 substrate
0,175  0,018  Antineoplastic (uterine cancer)
0,161  0,004  Melatonin agonist
0,206  0,050  Tumour necrosis factor antagonist
0,176  0,020  Mucolytic
0,195  0,043  Interferon gamma antagonist
0,194  0,042  Skeletal muscle relaxant
0,275  0,124  Stroke treatment
0,180  0,028  Antihemorrhagic
0,235  0,084  Tyrosine 3 hydroxylase inhibitor
0,281  0,130  Antiobesity
0,172  0,022  UGT2B1 substrate
0,162  0,013  GST T1-1 substrate
0,248  0,100  Antihypoxic
0,245  0,100  Antineoplastic (multiple myeloma)
0,172  0,027  Expectorant
0,212  0,068  Anesthetic general
0,190  0,047  Phobic disorders treatment
0,192  0,049  Antirickettsial
0,189  0,047  Antiparkinsonian, tremor relieving
0,246  0,104  Hypoxia-inducible factor 1 alpha inhibitor
0,177  0,039  Monophenol monooxygenase inhibitor
0,173  0,035  Platelet activating factor antagonist
0,236  0,098  Lipoprotein disorders treatment
0,179  0,041  SULT1A3 substrate
0,232  0,095  Antiprotozoal (Trypanosoma)
0,158  0,020  Calcium antagonist
0,235  0,098  Spasmolytic
0,154  0,018  Antifungal (Pneumocystis)
0,160  0,024  Ca2+-transporting ATPase inhibitor
0,150  0,015  UGT2B11 substrate
0,190  0,055  Antihelmintic (Nematodes)
0,160  0,026  EphA2 antagonist
0,166  0,032  Carcinogenic, group 2B
0,216  0,084  Hypolipemic
0,169  0,038  Alkylator
0,167  0,037  Cholesterol synthesis inhibitor
0,191  0,061  Muscle relaxant
0,152  0,023  Topoisomerase II alpha inhibitor
0,184  0,055  Aldehyde oxidase substrate
0,141  0,013  Postmenopausal disorders treatment
0,149  0,021  Electron transport complex I inhibitor
0,132  0,005  Kinesin-like protein 1 inhibitor
0,132  0,005  Kinesin antagonist
0,158  0,036  Alpha adrenoreceptor antagonist
0,174  0,053  Protein kinase stimulant
0,235  0,115  CYP2D6 substrate
0,152  0,036  Gastritis treatment
0,193  0,078  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,125  0,011  Glycine receptor agonist
0,193  0,082  Amyloid beta aggregation inhibitor
0,177  0,065  Toxic, respiratory center
0,173  0,062  Antianorexic
0,184  0,073  Antiviral (Hepatitis)
0,187  0,078  CYP2B6 inhibitor
0,113  0,005  Glutamate (mGluR7) antagonist
0,142  0,034  Bronchodilator
0,158  0,051  Adenylate cyclase stimulant
0,122  0,015  Granulocyte macrophage colony stimulating factor agonist
0,135  0,029  Acetylcholine release stimulant
0,128  0,022  Macrophage migration inhibitory factor inhibitor
0,122  0,017  Beta tubulin antagonist
0,236  0,133  Antineoplastic (osteosarcoma)
0,188  0,087  5 Hydroxytryptamine 3E antagonist
0,174  0,075  Antineoplastic (gastric cancer)
0,125  0,027  Paget's disease treatment
0,181  0,083  UDP-glucuronosyltransferase substrate
0,140  0,043  Contraceptive female
0,158  0,063  GABA C receptor rho-2 antagonist
0,187  0,097  Cardiodepressant
0,095  0,005  Alpha 1L adrenoreceptor antagonist
0,196  0,106  RNA-directed DNA polymerase inhibitor
0,131  0,042  HDL-cholesterol increasing
0,136  0,046  Alpha 2b adrenoreceptor antagonist
0,147  0,058  Pregnane X receptor agonist
0,140  0,050  Vanilloid 1 agonist
0,125  0,035  Prolactin inhibitor
0,116  0,027  Alpha 2d adrenoreceptor antagonist
0,105  0,017  Acetylcholine M5 receptor agonist
0,182  0,093  Insulin sensitizer
0,121  0,033  Phosphodiesterase IV inhibitor
0,124  0,038  Creatine kinase inhibitor
0,152  0,065  MAP kinase 3 inhibitor
0,109  0,022  Dopamine D1 antagonist
0,093  0,008  Dopamine D3 agonist
0,168  0,083  Lipocortins synthesis antagonist
0,162  0,078  Sigma receptor agonist
0,124  0,040  Obsessive-compulsive disorder treatment
0,109  0,025  Glycine receptor antagonist
0,101  0,018  Secretase beta inhibitor
0,125  0,043  Carbonic anhydrase XV inhibitor
0,265  0,183  Antiarthritic
0,130  0,048  Constipation treatment
0,115  0,035  Actinic keratosis treatment
0,114  0,034  Toll-Like receptor 3 antagonist
0,158  0,079  Prostate disorders treatment
0,089  0,011  Transcription factor RelA inhibitor
0,088  0,009  Postcoital contraceptive
0,103  0,025  Estrogen receptor alpha antagonist
0,094  0,016  Alpha tubulin antagonist
0,138  0,061  Toll-Like receptor 2 antagonist
0,138  0,062  Allergic rhinitis treatment
0,102  0,027  Alpha adrenoreceptor agonist
0,102  0,027  Thioredoxin reductase inhibitor
0,103  0,029  Keratolytic
0,132  0,058  Coagulant
0,150  0,078  Peroxidase inhibitor
0,206  0,134  Anxiolytic
0,083  0,012  Topoisomerase II beta inhibitor
0,173  0,104  Embryotoxic
0,150  0,080  Neuropathy treatment
0,117  0,047  Sulfotransferase substrate
0,126  0,057  Skin irritative effect
0,119  0,050  AMP-activated protein kinase stimulant
0,100  0,032  Na+ K+ transporting ATPase inhibitor
0,122  0,054  SULT1A1 substrate
0,101  0,034  Antiprotozoal activity enhancer
0,104  0,037  Glutamate release inhibitor
0,080  0,014  Calcium channel P-type blocker
0,108  0,043  Antineoplastic antibiotic
0,105  0,039  NADH dehydrogenase inhibitor
0,173  0,109  Teratogen
0,112  0,049  Antiadrenergic
0,150  0,086  Uterine stimulant
0,222  0,159  Sodium/bile acid cotransporter inhibitor
0,084  0,022  Alpha 1 adrenoreceptor agonist
0,110  0,048  Adrenaline antagonist
0,076  0,015  Acetylcholine M2 receptor agonist
0,289  0,228  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,155  0,095  Carcinogenic
0,102  0,043  Ornithine decarboxylase inhibitor
0,084  0,026  Aromatase inhibitor
0,083  0,025  Adrenaline uptake inhibitor
0,106  0,049  Glutamate (mGluR7) agonist
0,069  0,013  Progesterone antagonist
0,065  0,008  Guanylate cyclase inhibitor
0,160  0,104  Non-steroidal antiinflammatory agent
0,109  0,053  Carbonic anhydrase III inhibitor
0,070  0,015  Anesthetic inhalation
0,092  0,037  Estrogen-related receptor beta agonist
0,079  0,025  Glutamate (mGluR6) antagonist
0,173  0,119  Antiviral (Ebola)
0,058  0,005  Sodium/glucose cotransporter 2 inhibitor
0,063  0,010  Glucocorticoid antagonist
0,090  0,037  Ca(v)3.1 blocker
0,069  0,018  Alpha-mannosidase inhibitor
0,112  0,061  GABA C receptor antagonist
0,140  0,088  Eye irritation, high
0,120  0,071  Antiviral (Hepatitis B)
0,102  0,053  HIV-1 integrase (Overall Integration) inhibitor
0,086  0,038  Narcotic antagonist
0,095  0,047  Antiviral (Hepatitis A)
0,130  0,084  Lipid peroxidase inhibitor
0,077  0,030  SULT2A1 substrate
0,060  0,014  Microtubule stabilization
0,104  0,058  Anabolic
0,083  0,037  Benzodiazepine agonist
0,201  0,156  Nootropic
0,076  0,031  Exportin-1 inhibitor
0,091  0,046  mTOR complex 2 inhibitor
0,063  0,019  Potassium channel Kv1.3 blocker
0,218  0,174  Antiprotozoal (Plasmodium)
0,238  0,194  Analgesic
0,077  0,034  Dopamine D3 antagonist
0,101  0,059  Sphingomyelinase inhibitor
0,121  0,079  Papain-like protease (SARS coronavirus) inhibitor
0,053  0,013  Hypogonadism treatment
0,096  0,057  Bile acid receptor antagonist
0,186  0,147  5 Hydroxytryptamine 1E antagonist
0,097  0,058  Breast cancer-resistant protein inhibitor
0,065  0,026  Ryanodine receptor antagonist
0,044  0,006  Sodium/glucose cotransporter inhibitor
0,121  0,084  Contraceptive
0,141  0,105  Antipruritic
0,130  0,094  MAP3K9 inhibitor
0,095  0,059  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,079  0,043  Histidine decarboxylase inhibitor
0,068  0,032  Androgen agonist
0,126  0,090  Mannose-6-phosphate isomerase inhibitor
0,109  0,073  Photosensitizer
0,091  0,056  Antidote, mercury
0,117  0,083  Antismoking
0,081  0,047  Antidote, organophosphates
0,162  0,130  Antialcoholic
0,177  0,145  Radioprotector
0,045  0,013  Vanilloid 3 antagonist
0,054  0,022  Mannosidase inhibitor
0,069  0,037  5 Hydroxytryptamine 2A agonist
0,105  0,074  Protein-tyrosine phosphatase 1B inhibitor
0,043  0,012  Nucleoside transporters inhibitor
0,134  0,103  Heat shock protein 70 antagonist
0,081  0,050  NAD(P)H dehydrogenase (quinone) inhibitor
0,057  0,027  Glucose-6-phosphate translocase inhibitor
0,143  0,112  DNA methyltransferase I inhibitor
0,135  0,106  CF transmembrane conductance regulator agonist
0,135  0,106  Mcl-1 antagonist
0,112  0,085  Antiviral (Influenza B)
0,255  0,227  MAP kinase 1 inhibitor
0,041  0,014  Tubulin agonist
0,112  0,086  Alpha-N-acetylglucosaminidase inhibitor
0,060  0,034  Acetylcholine muscarinic agonist
0,096  0,072  Urease inhibitor
0,033  0,009  Sodium/glucose cotransporter 1 inhibitor
0,049  0,026  Dopamine D5 antagonist
0,077  0,054  Alpha 1 adrenoreceptor antagonist
0,027  0,005  NMDA receptor phencyclidine site antagonist
0,092  0,070  UDP-glucose 4-epimerase inhibitor
0,063  0,041  Antimycoplasmal
0,127  0,106  Phospholipase A2 inhibitor
0,083  0,062  Androgen antagonist
0,045  0,025  Cathepsin L2 inhibitor
0,043  0,024  Dopamine D5 agonist
0,070  0,051  Alpha 1a adrenoreceptor antagonist
0,074  0,055  Carbonic anhydrase XIII inhibitor
0,078  0,060  Carbonic anhydrase VI inhibitor
0,130  0,113  MAP kinase kinase 4 inhibitor
0,194  0,177  Angiogenesis inhibitor
0,066  0,050  MDM2 inhibitor
0,052  0,036  5 Hydroxytryptamine 2 agonist
0,064  0,048  Dopamine agonist
0,042  0,027  Kainate receptor agonist
0,057  0,042  Lipocortins synthesis agonist
0,049  0,034  HCV NS3/NS4A protease inhibitor
0,064  0,050  Leukotriene synthesis inhibitor
0,097  0,084  Multidrug resistance-associated protein 1 inhibitor
0,058  0,045  Potassium channel intermediate-conductance Ca-activated blocker
0,067  0,053  Anticholelithogenic
0,038  0,026  Glutamate (mGluR8) agonist
0,195  0,184  Antithrombotic
0,042  0,031  Acetylcholine M1 receptor agonist
0,048  0,038  Squalene epoxidase inhibitor
0,022  0,012  Imidazoline I1 receptor antagonist
0,033  0,023  Melatonin receptor 1A agonist
0,082  0,074  ATPase (Vacuolar H+) inhibitor
0,027  0,020  Hedgehog signaling activator
0,096  0,089  Antifungal (Aspergillus)
0,065  0,058  Dopamine antagonist
0,053  0,046  Dopamine uptake inhibitor
0,069  0,063  Nicotinic alpha4beta2 receptor antagonist
0,086  0,080  Dementia treatment
0,022  0,016  Prostaglandin F2 alpha agonist
0,029  0,024  Potassium channel (Inward rectifier) 1 blocker
0,045  0,039  Glucose-6-phosphate isomerase inhibitor
0,091  0,086  Excitatory amino acid transporter EAAC1 inhibitor
0,083  0,079  Vascular dementia treatment
0,044  0,040  Aldosterone antagonist
0,045  0,041  Potassium channel (Inward rectifier) blocker
0,057  0,054  Nitric oxide donor
0,054  0,051  Neuraminidase inhibitor
0,029  0,026  Cholesterol ester transfer protein antagonist
0,011  0,008  Imidazoline I2 receptor antagonist
0,087  0,084  Tourette's syndrome treatment
0,053  0,051  Pregnane X receptor antagonist
0,131  0,130  Platelet adhesion inhibitor
0,021  0,020  Dopamine D1 agonist
0,082  0,081  Restless leg syndrome treatment
0,062  0,062  Amidase inhibitor
0,047  0,047  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor

